基金经理：黄欣
| 单位净值:0.8202 | 净值增长率:-1.60% | 净值增长率:-1.60% | 累计净值:0.8202 | 截止日期:2024/9/6 | |
|---|---|---|---|---|---|
| 最新估值:-(-) | 涨跌幅:- | 涨跌额:- | |||
| 最新规模:0.57亿元 | 风险等级:高风险 | 申购状态:可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
国联安中证医药100C(006569)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2024/6/30 | 200,158,000 | - | 214,825,000 | 214,232,000 | 93% |
| 2024/3/31 | 214,763,000 | - | 231,038,000 | 230,339,000 | 93% |
| 2023/12/31 | 250,815,000 | - | 266,333,000 | 265,472,000 | 94% |
| 2023/9/30 | 251,978,000 | - | 272,684,000 | 272,032,000 | 93% |
| 2023/6/30 | 252,075,000 | - | 273,108,000 | 272,414,000 | 93% |
| 2023/3/31 | 314,623,000 | - | 338,291,000 | 337,436,000 | 93% |
| 2022/12/31 | 268,554,000 | - | 291,367,000 | 290,083,000 | 93% |
| 2022/9/30 | 186,310,000 | - | 206,224,000 | 202,101,000 | 92% |
| 2022/6/30 | 211,626,000 | - | 227,867,000 | 226,703,000 | 93% |
| 2022/3/31 | 200,608,000 | - | 220,602,000 | 219,792,000 | 91% |
| 2021/12/31 | 219,641,000 | - | 241,012,000 | 238,844,000 | 92% |
| 2021/9/30 | 195,000,000 | - | 213,557,000 | 212,886,000 | 92% |
| 2021/6/30 | 230,510,000 | - | 248,758,000 | 245,102,000 | 94% |
| 2021/3/31 | 1,219,660,000 | - | 1,303,120,000 | 1,301,010,000 | 94% |
| 2020/12/31 | 1,253,620,000 | - | 1,358,030,000 | 1,353,280,000 | 93% |
| 2020/9/30 | 2,319,740,000 | - | 2,587,620,000 | 2,583,760,000 | 90% |
| 2020/6/30 | 2,384,060,000 | - | 2,605,780,000 | 2,593,480,000 | 92% |
| 2020/3/31 | 1,933,240,000 | - | 2,082,070,000 | 2,077,590,000 | 93% |
| 2019/12/31 | 1,769,460,000 | - | 1,921,770,000 | 1,912,500,000 | 93% |
| 2019/9/30 | 1,737,340,000 | - | 1,858,850,000 | 1,856,040,000 | 94% |
| 2019/6/30 | 1,639,900,000 | - | 1,767,460,000 | 1,763,800,000 | 93% |
| 2019/3/31 | 1,760,080,000 | - | 1,923,080,000 | 1,910,000,000 | 92% |
| 2018/12/31 | 1,087,220,000 | - | 1,482,370,000 | 1,480,270,000 | 73% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。